APH vs PLRX · P/E 40, rev $23.09B vs $77.3M cap
Amphenol Corporation (APH) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the APH and PLRX stock pages for the full models.
Not investment advice.